Want to see HK:1419 full AI Analyst Report?
Top Page
Human Health Holdings Ltd.
(1419)
Select Model
Select Model
Rating:58Neutral
Price Target:
HK$0.81
▲(5.32% Upside)
Action:Reiterated
Date:06/15/26
The score is primarily held back by weaker and less consistent financial performance (notably the sharp margin reset and cash flow volatility) and bearish technicals (below major moving averages with negative MACD). Partially offsetting these risks are a solid balance sheet and a reasonable valuation supported by a moderate P/E and dividend yield.
Positive Factors
Balance sheet strength
Moderate leverage and substantial equity provide durable financial flexibility. With debt-to-equity near 0.17–0.25 the company can fund operations, absorb shocks, and support dividends or opportunistic investment without immediate refinancing stress, strengthening resilience over 2–6 months.
Negative Factors
Sharp margin compression
A collapse from ~18% to ~4% net margin materially reduces sustainable earnings power. If the margin reset reflects structural cost, pricing or mix shifts, it will impair ROE and free cash generation and could take many quarters to reverse, limiting medium-term profit durability.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet strength
Moderate leverage and substantial equity provide durable financial flexibility. With debt-to-equity near 0.17–0.25 the company can fund operations, absorb shocks, and support dividends or opportunistic investment without immediate refinancing stress, strengthening resilience over 2–6 months.
Read all positive factors
Human Health Holdings Ltd. (1419) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$292.26M
Dividend Yield3.9%
Average Volume (3M)32.80K
Price to Earnings (P/E)10.5
Beta (1Y)0.25
Revenue Growth9.74%
EPS Growth32.37%
CountryHK
Employees544
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.07
Shares Outstanding379,552,220
10 Day Avg. Volume56,600
30 Day Avg. Volume32,800
Financial Highlights & Ratios
PEG Ratio1.34
Price to Book (P/B)0.40
Price to Sales (P/S)0.49
P/FCF Ratio3.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Human Health Holdings Ltd. Business Overview & Revenue Model
Company Description
Operating as an investment holding company, Human Health Holdings Limited delivers a comprehensive range of healthcare services across Hong Kong. Its primary care offerings encompass a wide array of services such as routine consultations, diagnost...
Human Health Holdings Ltd. Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
72
Positive
Cash Flow
63
Positive
| Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 670.99M | 644.43M | 590.82M | 1.00B | 1.12B | 654.71M |
| Gross Profit | 274.24M | 296.57M | 269.85M | 593.24M | 659.68M | 376.69M |
| EBITDA | 103.79M | 52.32M | 104.06M | 323.46M | 513.25M | 238.36M |
| Net Income | 27.77M | 26.34M | 24.19M | 180.84M | 375.31M | 144.45M |
Balance Sheet | ||||||
| Total Assets | 1.05B | 1.07B | 1.06B | 1.26B | 1.16B | 612.39M |
| Cash, Cash Equivalents and Short-Term Investments | 475.56M | 439.90M | 489.58M | 641.26M | 270.33M | 145.26M |
| Total Debt | 174.22M | 134.54M | 146.46M | 182.49M | 188.47M | 67.08M |
| Total Liabilities | 266.99M | 290.22M | 289.71M | 455.27M | 416.67M | 202.26M |
| Stockholders Equity | 786.26M | 781.75M | 766.67M | 808.22M | 741.95M | 410.13M |
Cash Flow | ||||||
| Free Cash Flow | 122.35M | 89.54M | -28.17M | 580.24M | 219.30M | 71.44M |
| Operating Cash Flow | 129.93M | 97.30M | 11.34M | 664.26M | 295.81M | 85.49M |
| Investing Cash Flow | -277.88M | 3.71M | -47.63M | -335.34M | -203.22M | -4.77M |
| Financing Cash Flow | -83.40M | -93.63M | -122.66M | -178.28M | -67.45M | -59.30M |
Human Health Holdings Ltd. Technical Analysis
Positive
0.77
Price Trends
0.75
Positive
0.77
Positive
0.79
Negative
Market Momentum
<0.01
Negative
57.92
Neutral
34.72
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1419, the sentiment is Positive. The current price of 0.77 is above the 20-day moving average (MA) of 0.75, above the 50-day MA of 0.75, and below the 200-day MA of 0.79, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 57.92 is Neutral, neither overbought nor oversold. The STOCH value of 34.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1419.
Human Health Holdings Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | HK$320.38M | 9.78 | 4.28% | 8.25% | -2.78% | -24.77% | |
60 Neutral | HK$1.03B | 31.33 | 1.27% | ― | ― | ― | |
58 Neutral | HK$292.26M | 10.53 | 3.54% | 3.90% | 9.74% | 32.37% | |
54 Neutral | HK$469.86M | -145.50 | -0.41% | ― | 3.16% | -101.02% | |
53 Neutral | HK$1.23B | 84.76 | 0.48% | 1.02% | -3.26% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | HK$484.70M | -4.76 | -6.22% | ― | -27.63% | -16.33% |
* Healthcare Sector Average
HK:1419
Human Health Holdings Ltd.
0.77
-0.27
-25.96%
HK:2389
Beijing Health (Holdings) Limited
0.08
>-0.01
-4.71%
HK:3869
Hospital Corporation of China Ltd
3.40
-3.39
-49.93%
HK:3886
Town Health International Medical Group Ltd.
0.18
-0.09
-32.44%
HK:6639
Arrail Group Ltd.
1.83
-0.53
-22.50%
HK:0722
UMP Healthcare Holdings Limited
0.40
-0.05
-11.50%
Human Health Holdings Ltd. Corporate Events
Human Health Adjusts Profit Guarantee and Covers Shortfall on Monarch Dental Deal
Apr 20, 2026
Human Health Holdings has adjusted the profit guarantee arrangement tied to its acquisition of a 75% stake in Monarch Dental Clinic Limited, shifting the guarantee period to run from 1 March 2025 to 28 February 2030. The change reflects that the a...
Human Health flags profit shortfall at acquired Monarch Dental Clinic
Mar 31, 2026
Human Health Holdings Ltd. has disclosed that Monarch Dental Clinic Limited, in which it acquired a 75% stake, failed to meet the agreed profit guarantee for the year ended 31 December 2025. The clinic reported audited profit after tax of about HK...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.